HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wilfried Dinh Selected Research

Therapeutics

12/2021sGC stimulation lowers elevated blood pressure in a new canine model of resistant hypertension.
2/2021Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial.
10/2020Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment.
4/2017Reassessing Phase II Heart Failure Clinical Trials: Consensus Recommendations.
6/2016Molecular and Digital Biomarker Supported Decision Making in Clinical Studies in Cardiovascular Indications.
1/2016Partial adenosine A1 receptor agonism: a potential new therapeutic strategy for heart failure.
1/2016Developing New Treatments for Heart Failure: Focus on the Heart.
7/2015Site selection for heart failure clinical trials in the USA.
8/2014Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries.
3/2010Gender-based differences in long-term outcome after ST-elevation myocardial infarction in patients treated with percutaneous coronary intervention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wilfried Dinh Research Topics

Disease

20Heart Failure
12/2021 - 07/2010
3Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 07/2011
3Systolic Heart Failure
10/2016 - 07/2011
2Hypertension (High Blood Pressure)
12/2021 - 11/2009
2Left Ventricular Dysfunction
11/2017 - 07/2011
2Glucose Intolerance
06/2011 - 10/2010
2Coronary Artery Disease (Coronary Atherosclerosis)
11/2009 - 01/2009
2Diabetes Mellitus
11/2009 - 01/2009
2Glucose Metabolism Disorders
11/2009 - 01/2009
2Myocardial Infarction
07/2009 - 06/2009
1Stroke (Strokes)
12/2021
1Body Weight (Weight, Body)
02/2021
1Cardiomyopathies (Cardiomyopathy)
05/2020
1Fibrosis (Cirrhosis)
01/2019
1Cardiomegaly (Heart Hypertrophy)
01/2019
1Chronic Renal Insufficiency
03/2018
1Chest Pain (Chest Pains)
11/2017
1Ventricular Dysfunction
01/2017
1Ventricular Remodeling
01/2017
1Mitochondrial Diseases (Mitochondrial Disease)
01/2017
1Neoplasms (Cancer)
01/2016
1Hypotension (Low Blood Pressure)
01/2016
1Cardiac Sudden Death (Sudden Cardiac Arrest)
03/2012
1Prediabetic State (Prediabetes)
07/2011
1Esophageal Fistula
10/2010
1Tachycardia (Tachyarrhythmias)
10/2010
1ST Elevation Myocardial Infarction
03/2010
1Coronary Disease (Coronary Heart Disease)
11/2009
1Infarction (Infarctions)
06/2009
1Inflammation (Inflammations)
01/2009

Drug/Important Bio-Agent (IBA)

8Biomarkers (Surrogate Marker)IBA
05/2020 - 07/2011
4Glucose (Dextrose)FDA LinkGeneric
07/2011 - 01/2009
3Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
02/2021 - 01/2019
2Vasopressins (Vasopressin)IBA
01/2021 - 01/2019
2Adenosine (Adenocard)FDA LinkGeneric
01/2017 - 01/2017
2Adenosine A1 ReceptorIBA
01/2017 - 01/2016
2CytokinesIBA
07/2011 - 11/2009
13- (4- Amino- 5- cyclopropylpyrimidine- 2- yl)- 1- (2- fluorobenzyl)- 1H- pyrazolo(3,4- b)pyridineIBA
12/2021
1Soluble Guanylyl CyclaseIBA
12/2021
1CreatinineIBA
02/2021
1Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA
02/2021
1Antidiuretic Hormone Receptor AntagonistsIBA
02/2021
1Urea (Carbamide)FDA LinkGeneric
02/2021
1NitrogenIBA
02/2021
1Arginine Vasopressin (Argipressin)IBA
01/2021
1sinistrinIBA
03/2018
1Natriuretic PeptidesIBA
11/2017
1EndostatinsIBA
11/2017
1TroponinIBA
11/2017
1neladenoson bialanateIBA
01/2017
1Insulin-Like Growth Factor I (IGF-1)IBA
10/2016
1Carrier Proteins (Binding Protein)IBA
10/2016
1insulin-like growth factor binding protein-related protein 1IBA
10/2016
1Insulin (Novolin)FDA Link
10/2016
1Analgesics (Analgesic Drugs)IBA
03/2012
1Hypnotics and Sedatives (Sedatives)IBA
03/2012
1Brain Natriuretic Peptide (Natrecor)FDA Link
07/2011
1Fatty Acid Binding Protein 3IBA
07/2011
1Troponin T (Troponin T1)IBA
07/2011
1Growth Differentiation Factor 15IBA
07/2011
1Transforming Growth Factors (Transforming Growth Factor)IBA
07/2011
1Pro-BNP1-108IBA
07/2010
1Interleukin-6 (Interleukin 6)IBA
11/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2009
1Tissue Inhibitor of Metalloproteinase-1IBA
07/2009
1EnzymesIBA
07/2009
1Laminin (Merosin)IBA
06/2009
1Collagen Type VIIBA
06/2009
1SelectinsIBA
01/2009
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2009
1P-SelectinIBA
01/2009

Therapy/Procedure

10Therapeutics
12/2021 - 03/2010
1Artificial Respiration (Mechanical Ventilation)
03/2012
1Length of Stay
03/2012
1Analgesia
03/2012
1Radiofrequency Ablation
10/2010
1Percutaneous Coronary Intervention
03/2010